Related Experiment Video
Updated: Jun 20, 2026

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
Published on: December 22, 2017
Clinical sequelae of thrombus in an inferior vena cava filter
Iftikhar Ahmad1, Kalpana Yeddula, Stephan Wicky
1Department of Radiology, Massachusetts General Hospital and Harvard Medical School, GRB-297, 55 Fruit Street, Boston, MA 02114, USA.
Insights
Inferior vena cava (IVC) filter thrombus is common and often asymptomatic. Anticoagulation showed little effect on thrombus resolution or future pulmonary embolism (PE) risk.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiology
Background:
- Inferior vena cava (IVC) filters are used to prevent pulmonary embolism (PE).
- Thrombus formation within IVC filters is a known complication.
- The long-term clinical impact of IVC filter thrombus and the role of anticoagulation remain areas of investigation.
Purpose of the Study:
- To assess the long-term clinical sequelae of IVC filter thrombus.
- To evaluate the effect of anticoagulation on IVC filter thrombus progression and regression.
Main Methods:
- Retrospective review of 1,718 patients who underwent IVC filter placement between 2001-2008.
- Follow-up abdominal CT scans were analyzed for filter thrombus in 598 patients.
- Statistical analysis, including Fisher exact test, was used to assess the impact of anticoagulation.
Main Results:
- Filter thrombus was detected in 18.6% of patients on follow-up CT.
- The majority of filter thrombi were asymptomatic (18.3%).
- Anticoagulation did not significantly affect thrombus regression or progression rates, nor the occurrence of PE.
Conclusions:
- Asymptomatic IVC filter thrombus is a frequent finding and rarely progresses to complete caval occlusion.
- Anticoagulation appears to have minimal impact on the resolution of filter thrombus and the future risk of PE.
Abstract:
The purpose of this study was to assess the long-term clinical sequelae of inferior vena cava (IVC) filter thrombus and the effect of anticoagulation on filter thrombus. Of 1,718 patients who had IVC filters placed during 2001-2008, 598 (34.8%) had follow-up abdominal CT. Filter thrombus was seen in 111 of the 598 (18.6%). There were 44 men (39.6%). The mean age at filter placement was 64 years. The medical diseases included cancer in 64, trauma in 15, stroke in 12, and others in 20. The frequency of filter thrombus on CT and asymptomatic filter thrombus on CT was calculated. The frequency of pulmonary embolism (PE) in patients with filter thrombus was calculated. The frequency of thrombus progression or regression (on CT, available in 56) was calculated. The effect of anticoagulation on filter thrombus regression/progression was evaluated using the Fisher exact test by comparing the group of patients who received anticoagulants versus those who did not. A P-value of <0.05 was considered significant. The overall frequency of filter thrombus was 18.6%. Total occlusion of the IVC filter was seen in 12 of 598 (2%). The filter thrombus was asymptomatic in 110 (18.3%). Filter thrombus was detected after a median of 35 days (range, 0-2082) following filter placement. Thrombus extended above the filter in 4 (3.6%); IVC thrombus below the filter was seen in 35(31.5%). Thrombus in the filter occluded <25% of the filter volume in 58 (52.3%), 25-50% in 21 (18.9%), and 50-75% in 20 (18%). Total IVC occlusion was seen in 12 (10.8%). Eighty-three patients received anticoagulation. Sixteen patients developed symptoms of PE. PE was confirmed on CT in 3 of 15 (2.7%). On follow-up, filter thrombus regressed completely in 19 (33.9%) after a median of 6 months. Filter thrombus decreased in size in 13 (23.2%) and it progressed without IVC occlusion in 7 (12.6%). In one (1.7%), filter thrombus progressed to IVC occlusion. Filter thrombus remained stable in 16 (28.6%). There was no significant difference in thrombus regression or progression rates whether or not the patients received anticoagulation for filter thrombus. In conclusion, asymptomatic thrombus in the filter is common and it rarely progresses to complete caval occlusion. Anticoagulation has little effect on the resolution of filter thrombosis and future occurrence of PE.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism I: Introduction

